Article
G2677T polymorphism can predict treatment outcome of Malaysians with complex partial seizures being treated with Carbamazepine.
Genetics and molecular research : GMR - 26 Nov 2013
Subenthiran S, Abdullah N R, Muniandy P K, Joseph J P, Cheong K C, Ismail Z, Mohamed Z
Abstract excerpt
Carbamazepine (CBZ) is used as the first line of treatment of complex partial seizures (CPS) in Malaysia. While this drug is known to be effective for the treatment of CPS, more than 30% of patients remain drug resistant to CBZ mono-therapy. We examined a possible relationship between patients' response to CBZ mono-therapy and the G2677T SNP of the ABCB1 gene. Three hundred and fourteen patients with CPS were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
